An investigation into medication practices in the United Kingdom has highlighted a growing crisis of overprescribing among elderly patients, leading to thousands of admissions to emergency hospital care daily due to adverse drug reactions. Research shows that nearly eight million people are at risk of side effects because they are prescribed five or more medications daily—a threshold known as polypharmacy—while around 2.2 million individuals take ten or more drugs each day. Experts say that the accumulation of medications in older, often frail patients can result in falls, dizziness, low blood pressure, irregular heart rhythms, and symptoms resembling dementia.
Analysis of NHS data reveals that approximately 1,000 elderly patients are admitted each day with preventable medication-related complications. Some patients have been on drugs prescribed decades earlier for conditions such as high blood pressure, which may become harmful as the body ages and physiological responses change. Side effects from one medication are sometimes mistaken for new illnesses, leading to the prescription of additional drugs that further increase risks.
A notable case involves Peter Eustace, a 96-year-old man with severe Alzheimer’s disease, who had been taking tamsulosin—a medication for prostate symptoms—years after undergoing prostate removal surgery. His geriatric review uncovered that he was also taking other unnecessary drugs, including statins and ramipril, which may have contributed to his falls and decline before his death in 2024. Eustace’s experience underscores concerns that patients often receive repeated prescriptions without comprehensive review, while communication between healthcare providers sometimes fails to consider the broader context of a patient’s health and age.
General practitioners are expected to conduct frailty assessments and medication reviews for older patients, yet only 17 percent of those over 65 received such checks in 2024-25. Even among patients identified with severe frailty, just 16 percent had a medication review. Medical training in geriatric medicine is limited, with students receiving only four to eight weeks of instruction over five years and NHS trainees getting a maximum of six months in elderly care. The shortage of geriatricians—around 1,600 currently practicing in England—places additional strain on primary care services, limiting the capacity for thorough assessments.
Leading clinicians including Jugdeep Dhesi, president of the British Geriatrics Society, have called on regulatory bodies and health authorities to recognize the “growing threat to patient safety” posed by polypharmacy. They advocate for enhanced medical education on the risks associated with multiple medications, routine reviews for frail patients taking ten or more drugs, and significantly expanding the workforce of geriatric specialists by training at least 1,850 more by 2030 to better support the elderly population.
The NHS acknowledges the need for improved care for aging patients and has issued guidance encouraging regular medication reviews and community support for frailty. A national plan for elderly care, expected in January, aims to establish modern standards addressing these challenges. While alternatives to medication and more holistic approaches to treatment are being explored, experts warn that current systemic issues—such as fragmented care, time pressures on GPs, and insufficient geriatric training—must be addressed to prevent further harm and reduce the significant annual cost to the NHS, estimated at over £2 billion due to complications related to overprescribing.